National Health Investors Inc expected to post earnings of 68 cents a share - Earnings Preview

National Health Investors

04/05/2024 02:08

* National Health Investors Inc  NHI.N   NHI  is expected
to show
a fall in quarterly revenue when it reports  results on May 6
for the period ending March 31 2024
    * The Murfreesboro Tennessee-based  company is expected to
report
a 6.7% decrease in revenue to $76.851 million from $82.39
million a year ago, according to the mean estimate from 4
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for National Health
Investors Inc
is for earnings of 68 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for National
Health
Investors Inc is $64.50​, below​ its last closing price
of $64.72. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  1.07        1.07       1.09      Beat    1.7
 Sep. 30 2023  1.08        1.08       1.08      Met     0
 Jun. 30 2023  1.08        1.08       1.06      Missed  -2.3​
 Mar. 31 2023  0.99        1.00       1.11      Beat    11.4
 ​​Dec.        1.09        1.09       0.85      Missed  -22.2
 31 2022                                                
 Sep. 30 2022  1.06        1.07       1.06      Missed  -0.6​
 Jun. 30 2022  1.21        1.21       1.26      Beat    4.4
 Mar. 31 2022  1.13        1.10       1.10      Met     -0.2
 This summary was machine generated May 4 at 01:08 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)